A new article published by Dovepress Journal examines the impact of patient cost sharing for antihypertensive medications on adherence, utilization, and expenditures. The trend has been for managed care organizations and employers to require patients to bear a greater out-of-pocket burden for healthcare resources consumed. This study illustrates the potential adverse effects of higher patient cost sharing among patients with hypertension stratified by different risk levels. A decrease in the proportion of days covered was predictive of higher resource utilization and healthcare costs, which should be of interest to payors and employers alike.
Read the article here.